Roman Palitsky
Emory University, GA·Psychology·Early-career
Psychedelics have shown strong potential to help with several mental health conditions that are hard to treat. But some people have adverse effects (AEs) that persist after the drug experience ends, and existing questionnaires capture these poorly.
- Fields
Psychology
Medicine & Clinical Research
Public Health & Epidemiology
- Topics
psychedelics
psychedelic-assisted therapy
adverse effects
- Grants
- 1 known grant, through Jul 2031
What they work on
- Validate and optimize a preliminary questionnaire measuring post-acute adverse effects of psychedelics, previously developed by the PI, in about 940 people from clinical trial and community samples.
- Characterize profiles of persisting psychedelic adverse effects that are linked to high impairment, using a longitudinal study of about 400 people surveyed six times over one year.
- Build expert consensus on strategies to prevent persisting psychedelic adverse effects and to reduce them once they occur, using a Delphi panel of about 25 experts.
More about the research
Without a good way to define and measure these lasting harms, it is hard to make psychedelic-assisted therapies safer, prevent harms, or treat them when they happen.
Why it matters
As psychedelic-assisted therapies move into clinics, people receiving them, and people using psychedelics in the community, could benefit from better ways to detect and handle lasting harms. A validated measure could improve safety monitoring and pharmacovigilance in clinical trials, and expert-agreed prevention strategies may help clinicians and harm-reduction programs reduce or treat persisting adverse effects.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Piper Ranallo
University of Minnesota, MN·Computer Science·Early-career
Build machine-readable ontology models that define mental, behavioral and social processes, findings, assessment instruments and interventions, using borderline personality disorder and psychosis as test cases.
Vanessa Brown
Emory University, GA·Psychology
Validate a new computational model of multi-step avoidance behavior by combining neural and behavioral data collected from people.
Jessica Rubin
University of California-San Francisco, CA·Medicine & Clinical Research·Early-career
Describe how pain is managed in patients with cirrhosis and measure rates of and risk factors for adverse outcomes tied to pain medications, using a cohort of over 500,000 Veterans built from national Veterans Health Administration electronic health records.
The school
Emory University: 70 labs on PI Pages, $1.2B a year on research, 286 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.